Janus Henderson Group
PRCT icon

Janus Henderson Group’s Procept Biorobotics PRCT Stock Holding History

Janus Henderson Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.61M Buy
384,246
+43,405
+13% +$1.22M ﹤0.01% 779
2025
Q4 		$10.7M Buy
340,841
+315,065
+1,222% +$10.4M ﹤0.01% 735
2025
Q3 		$920K Buy
25,776
+2,880
+13% +$132K ﹤0.01% 1706
2025
Q2 		$1.32M Hold
22,896
– – ﹤0.01% 1484
2025
Q1 		$1.38M Hold
22,896
– – ﹤0.01% 1465
2024
Q4 		$1.84M Sell
22,896
-1,400
-6% -$120K ﹤0.01% 1355
2024
Q3 		$1.95M Hold
24,296
– – ﹤0.01% 1328
2024
Q2 		$1.48M Buy
24,296
+5,775
+31% +$343K ﹤0.01% 1400
2024
Q1 		$914K Buy
18,521
+1
+0% +$48 ﹤0.01% 1688
2023
Q4 		$777K Sell
18,520
-56
-0.3% -$1.91K ﹤0.01% 1768
2023
Q3 		$609K Buy
18,576
+27
+0.1% +$920 ﹤0.01% 1830
2023
Q2 		$656K Buy
+18,549
New +$613K ﹤0.01% 1833

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group's PRCT Position: Q1 2026 in Review

Janus Henderson Group increased its Procept Biorobotics (PRCT) stake by 13% in Q1 2026, buying an estimated $1.22M and bringing the position to 384,246 shares worth $9.61M. The position accounts for ﹤0.01% of the portfolio, ranked #779.

Janus Henderson Group first reported a position in PRCT in Q2 2023 and has held it in 12 quarters since. The position peaked at $10.7M in Q4 2025. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Janus Henderson Group held 384,246 shares of Procept Biorobotics worth $9.61M as of Q1 2026.
  • Janus Henderson Group bought 43,405 Procept Biorobotics shares in Q1 2026, an estimated $1.22M.
  • Procept Biorobotics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #779 holding.
  • Janus Henderson Group first reported a position in Procept Biorobotics in Q2 2023 and has held it in 12 quarters since.
  • Janus Henderson Group's Procept Biorobotics position peaked at $10.7M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.